Cormorant Asset Management LP 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
Cormorant Asset Management LP | 3,025,000 6.110% |
632,703 (+26.45%) |
Filing |
| 2021-02-16 3:12 pm Sale |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
Cormorant Asset Management LP | 2,392,297 4.960% |
-1,004,353 (-29.57%) |
Filing |